Advertisement
| cost benefit analysis therapy: Cost-Benefit Analysis Richard Layard, Stephen Glaister, 1994-06-30 Covering all the main problems that arise in a typical cost-benefit exercise, this second edition reflects the most recent research in the area. It considers the main theoretical issues, the problem of ascribing a monetary value to things and includes six separate case studies. |
| cost benefit analysis therapy: Disease Control Priorities, Third Edition (Volume 4) Vikram Patel, Dan Chisholm, Tarun Dua, Ramanan Laxminarayan, Mari'a Lena Medina-Mora, Theo Vos, 2016-03-10 Mental, neurological, and substance use disorders are common, highly disabling, and associated with significant premature mortality. The impact of these disorders on the social and economic well-being of individuals, families, and societies is large, growing, and underestimated. Despite this burden, these disorders have been systematically neglected, particularly in low- and middle-income countries, with pitifully small contributions to scaling up cost-effective prevention and treatment strategies. Systematically compiling the substantial existing knowledge to address this inequity is the central goal of this volume. This evidence-base can help policy makers in resource-constrained settings as they prioritize programs and interventions to address these disorders. |
| cost benefit analysis therapy: The Implications of Cost-effectiveness Analysis of Medical Technology , 1980 |
| cost benefit analysis therapy: Mental Health Economics Denise Razzouk, 2017-08-26 The main objective of this work is to provide a book with high quality content that becomes a reference and support for graduate course (Mental Health, Public Health and Epidemiology) and for research in the domain of health economics applied to mental health. Also this book might be useful for policymakers on formulating mental health policies. Key messages of this book are based on: a) mental illness represent a huge cost for society and for health care; b) health economics applied to mental health could help in the optimization of resource allocation for mental health care and for better decision making in terms of balancing costs and benefits; c) interventions and treatment should be also chosen in general medical practice and in public decision-policy according to cost-effectiveness, burden of disease and equity principles; d) quality of care is related with better outcomes, higher quality of life for clients, and with lower costs for society and health system (best value for money); e) it is possible to decrease the burden of mental disorders with cost-effective treatments. The book is divided in four main topics: 1. Introduction to Health Economics applied to Mental Health – this section is an overview of basic principles, concepts and methods used in Economics and Health Economics to enable students to make critical appraisal of Health Economics texts and also to design research studies in this topic. 2. Health Economics applied to the evaluation of quality and costs of Mental Health Services – this section presents results of Brazilian studies on the costs of mental health care (hospital, outpatient care, residential care, informal care), methods on the measurement of costs and it discusses issues related with public policies decisions and quality of mental health car in the low and middle income countries context. There is also an overview of quality indicators of mental health care and instruments to evaluate mental health services and costs.3. Health Economics applied to evaluate treatment of mental disorders - This section presents a review of cost-effectiveness of pharmacological treatments and other interventions applied for treating the most burdensome mental disorders such as depressive and anxiety disorders, bipolar disorders, psychosis, alcohol and drug disorders, dementia, and hyper attention deficit disorders. 4. Health Economics, burden and indirect costs of mental disorders - This section highlights the social and economic burden caused by mental illness under societal perspective focusing on stigma, unemployment, indirect costs in the workplace (absenteeism and presenteeism), the relationship between poverty and mental disorders, global health and social determinants of mental health and on the costs of mental disorders (depression, anxiety, psychosis, alcohol and drug disorders). We present some instruments to measure indirect costs of mental disorders. |
| cost benefit analysis therapy: The Implications of Cost-effectiveness Analysis of Medical Technology , 1980 |
| cost benefit analysis therapy: A Cost-benefit Analysis of Model Hypertension Control John Stokes, Duncan C. Carmichael, 1975 In order to provide a basis from which to construct an estimate of the benefit- to-cost ratio it was necessary to make a number of assumptions such as those which relate to costs for secondary screening and the correlation between coronary heart disease and elevated diastolic blood pressure . In making those assumptions , this study recognizes the fact that should they be in error the conclusions which this study has reached may be subject to modification. This study is limited to ambulatory care of essential hypertension and does not address detection or therapy of any secondary forms of high blood pressure. |
| cost benefit analysis therapy: Principles of Social Psychiatry Craig Morgan, Dinesh Bhugra, 2010-06-14 Social psychiatry is concerned with the effects of the social environment on the mental health of the individual, and with the effects of the person with a mental disorder on his/her social environment. The field encompasses social interventions, prevention and the promotion of mental health. This new edition of Principles of Social Psychiatry provides a broad overview of current thinking in this expanding field and will be a source of ideas both in research and for the management of mental disorder. It opens by putting social psychiatry in perspective, within both psychiatry and the social sciences. From the patient's perspective, the outermost influence is the culture in which they live, followed by their neighbourhoods, workmates, and friends and family. The next section considers how we conceptualize the social world, from families through cultural identify and ethnicity to the wider social environment. The book reviews the social determinants and consequences of the major mental disorders before considering interventions and service delivery at various levels to mitigate these. It closes with a review of the social impact of mental illness around the world and a thoughtful essay by the editors on the current state of social psychiatry and where it is heading. |
| cost benefit analysis therapy: Exposure Therapy for Anxiety Jonathan S. Abramowitz, Brett J. Deacon, Stephen P. H. Whiteside, 2019-04-09 Now revised and expanded to include cutting-edge acceptance-based techniques and a new focus on inhibitory learning, this is the leading guide to therapeutic exposure, a crucial element of evidence-based psychological treatments for anxiety. The book helps the clinician gain skills and confidence for implementing exposure successfully and tailoring interventions to each client's needs, regardless of diagnosis. The theoretical and empirical bases of exposure are reviewed and specialized assessment and treatment planning techniques are described. User-friendly features include illustrative case examples, sample treatment plans, ideas for exercises targeting specific types of fears, and reproducible handouts and forms that can be downloaded and printed in a convenient 8½ x 11 size. New to This Edition *Chapter on acceptance and commitment therapy (ACT) techniques. *Reflects a shift in the field toward inhibitory learning--helping clients learn to tolerate anxiety and uncertainty to maximize long-term outcomes. *Chapter on uses of technology, such as computer-based therapy and virtual reality tools. *Conceptual, empirical, and clinical advances woven throughout. See also the related client recommendation, The Anxiety and Worry Workbook, Second Edition, by David A. Clark and Aaron T. Beck. |
| cost benefit analysis therapy: Health System Efficiency Jonathan Cylus, Irene Papanicolas, Peter C. Smith, 2016-12-15 In this book the authors explore the state of the art on efficiency measurement in health systems and international experts offer insights into the pitfalls and potential associated with various measurement techniques. The authors show that: - The core idea of efficiency is easy to understand in principle - maximizing valued outputs relative to inputs, but is often difficult to make operational in real-life situations - There have been numerous advances in data collection and availability, as well as innovative methodological approaches that give valuable insights into how efficiently health care is delivered - Our simple analytical framework can facilitate the development and interpretation of efficiency indicators. |
| cost benefit analysis therapy: The Implications of Cost-effectiveness Analysis of Medical Technology : Background Paper #2 United States. Congress. Office of Technology Assessment, 1981 |
| cost benefit analysis therapy: Distributional Cost-Effectiveness Analysis Richard Cookson, Susan Griffin, Ole F. Norheim, Anthony J. Culyer, 2020 Distributional cost-effectiveness analysis aims to help healthcare and public health organizations make fairer decisions with better outcomes. It can provide information about equity in the distribution of costs and effects - who gains, who loses, and by how much - and the trade-offs that sometimes occur between equity and efficiency. This is a practical guide to methods for quantifying the equity impacts of health programmes in high, middle, and low-income countries. The methods can be tailored to analyse different equity concerns in different decision making contexts. The handbook provides both hands-on training for postgraduate students and analysts and an accessible guide for academics, practitioners, managers, policymakers, and stakeholders. Part I is an introduction and overview for research commissioners, users, and producers. Parts II and III provide step-by-step guidance on how to simulate and evaluate distributions, with accompanying spreadsheet training exercises. Part IV concludes with discussions about how to handle uncertainty about facts and disagreement about values, and the future challenges facing this growing field. Book jacket. |
| cost benefit analysis therapy: Common Mental Health Disorders National Collaborating Centre for Mental Health (Great Britain), 2011 Bringing together treatment and referral advice from existing guidelines, this text aims to improve access to services and recognition of common mental health disorders in adults and provide advice on the principles that need to be adopted to develop appropriate referral and local care pathways. |
| cost benefit analysis therapy: Behavior and Cognitive Therapy Today European Association for Behavioral and Cognitive Therapies. Congress, 1998-10-18 This book carries the Proceedings of the European Association for Behavioural and Cognitive Therapy conference held in Venice in September 1997 and is dedicated to the memory of Hans Eysenck. The EACBT conference provides a rare opportunity for a wide range of clinicians and researchers from all over Europe and the USSR to come together, resulting in a highly topical and valuable range of scientific presentations. The Proceedings comprises over twenty papers addressing key subjects in terms of behavioural and cognitive therapy including panic, affective disorders, paraphilia, schizophrenia, PTSD, obsession and other psychological disorders. Of particular interest are chapters on the use of cognitive behaviour therapy versus supportive therapy in social phobia (Cottraux), the psychological treatment of paraphilias (De Silva), the theory and treatment of PTSD (Foa), the use of Diagnostic Profiling System in treatment planning (Freeman) and a cognitive theory of obsession (Rachman). |
| cost benefit analysis therapy: Measuring and Improving Cost, Cost-effectiveness, and Cost-benefit for Substance Abuse Treatment Programs Brian T. Yates, 1999 |
| cost benefit analysis therapy: Reducing Inappropriate Medicare Spending United States. Congress. Senate. Committee on Finance. Subcommittee on Medicare and Long-Term Care, 1992 |
| cost benefit analysis therapy: Research Methods in Family Therapy Douglas H. Sprenkle, Fred P. Piercy, 2005-06-01 In this widely adopted text and professional reference, leading contributors provide the knowledge needed to design strong qualitative, quantitative, and mixed-method studies; analyze the resulting data; and translate findings into improved practices and programs. Following a consistent format, user-friendly chapters thoroughly describe the various methodologies and illustrate their applications with helpful concrete examples. |
| cost benefit analysis therapy: Biomarkers in Drug Development Michael R. Bleavins, Claudio Carini, Mallé Jurima-Romet, Ramin Rahbari, 2011-09-20 Discover how biomarkers can boost the success rate of drug development efforts As pharmaceutical companies struggle to improve the success rate and cost-effectiveness of the drug development process, biomarkers have emerged as a valuable tool. This book synthesizes and reviews the latest efforts to identify, develop, and integrate biomarkers as a key strategy in translational medicine and the drug development process. Filled with case studies, the book demonstrates how biomarkers can improve drug development timelines, lower costs, facilitate better compound selection, reduce late-stage attrition, and open the door to personalized medicine. Biomarkers in Drug Development is divided into eight parts: Part One offers an overview of biomarkers and their role in drug development. Part Two highlights important technologies to help researchers identify new biomarkers. Part Three examines the characterization and validation process for both drugs and diagnostics, and provides practical advice on appropriate statistical methods to ensure that biomarkers fulfill their intended purpose. Parts Four through Six examine the application of biomarkers in discovery, preclinical safety assessment, clinical trials, and translational medicine. Part Seven focuses on lessons learned and the practical aspects of implementing biomarkers in drug development programs. Part Eight explores future trends and issues, including data integration, personalized medicine, and ethical concerns. Each of the thirty-eight chapters was contributed by one or more leading experts, including scientists from biotechnology and pharmaceutical firms, academia, and the U.S. Food and Drug Administration. Their contributions offer pharmaceutical and clinical researchers the most up-to-date understanding of the strategies used for and applications of biomarkers in drug development. |
| cost benefit analysis therapy: Manual of Hypertension of the European Society of Hypertension Giuseppe Mancia, Guido Grassi, 2014-06-22 Despite recent advances in healthcare, hypertension is a leading cause of death and remains a disease burden worldwide. Now in its second edition, the Manual of Hypertension of the European Society of Hypertension reflects emerging concepts that have the potential to impact diagnostic and therapeutic approaches to this condition. Updating all mater |
| cost benefit analysis therapy: Advances in Clinical Child Psychology Benjamin B. Lahey, 2013-11-11 Psychologists have long been interested in the problems of children, but in the last 20 years this interest has increased dramatically. The in tensified focus on clinical child psychology reflects an increased belief that many adult problems have their origin in childhood and that early treatment is often more effective than treatment at later ages, but it also seems to reflect an increased feeling that children are inherently important in their own right. As a result of this shift in emphasis, the number of publications on this topic has multiplied to the extent that even full-time specialists have not been able to keep abreast of all new developments. Researchers in the more basic fields of child psychol ogy have a variety of annual publications and journals to integrate research in their areas, but there is a marked need for such an integra tive publication in the applied segment of child and developmental psychology. Advances in Clinical Child Psychology is a serial publication designed to bring together original summaries of the most important developments each year in the field. Each chapter is written by a key figure in an innovative area of research or practice or by an individual who is particularly well qualified to comment on a topic of major contemporary importance. Each author has followed the stan dard format in which his or her area of research was reviewed and the clinical implications of the studies were made explicit. |
| cost benefit analysis therapy: Endometriosis Linda C. Giudice, MD, Johannes L. H. Evers, MD, David L. Healy, 2012-01-18 Written by an internationally well-known editor team, Endometriosis: Science and Practice is a state-of-the-art guide to this surprisingly common disease. While no cause for endometriosis has been determined, information of recent developments are outlined in this text, offering insight to improve management of symptoms medically or surgically. The first of its kind, this major textbook integrates scientific and clinical understanding of this painful disease helping to provide better patient care. |
| cost benefit analysis therapy: Reviving Rationality Michael A. Livermore, Richard L. Revesz, 2020-12-07 Politics and regulation -- A threatening synthesis -- Staying in bounds -- A retreat from reason -- The illusion of costs without benefits -- Erasing public health science -- Resurrecting discredited models -- Ignoring indirect benefits -- Trivializing climate change -- Manipulating transfers -- Future directions -- Improving the guardrails. |
| cost benefit analysis therapy: Research for the Radiation Therapist Cailtin Gillan, Lisa DiProspero, Nicole Harnett, Lori Holden, 2014-02-07 This book addresses a wide range of topics, from the principles of evidence-based practice to the process and dissemination of research to unique considerations such as clinical trials, patenting, and health services research. The case for evidence-based practice and a collaborative research culture is made first, followed by a series of chapters walking the reader through the research process by way of the scientific method. One of the more unique aspects of the scope of this book is the inclusion of chapters relating to the dissemination of knowledge, manuscript publication, and how to build an academic research program. Each chapter focuses on introducing the reader to foundational principles, methodology, and terminology, and highlight case studies of radiation therapist research or experience that is relevant to provide contextual examples and inspiration to the reader. |
| cost benefit analysis therapy: The Effectiveness and Costs of Alcoholism Treatment Leonard Saxe, United States. Congress. Office of Technology Assessment, 1983 |
| cost benefit analysis therapy: Cognitive Therapy Techniques, Second Edition Robert L. Leahy, 2017-03-03 Subject Areas/Keywords: anger, approval seeking, assumptions, avoidance, basics, CBT, challenging, clinical practice, cognitive distortions, cognitive therapy, cognitive-behavioral therapy, CT, decision making, distortion, eliciting, emotion regulation, emotional processing, emotions, evaluating, examining, forms, homework, interventions, intrusive, logical errors, modifying, practitioners, psychotherapists, psychotherapy, schemas, self-criticism, skills, strategies, techniques, testing, therapists, thoughts, training DESCRIPTION This indispensable book has given many tens of thousands of practitioners a wealth of evidence-based tools for maximizing the power of cognitive therapy and tailoring it to individual clients. Leading authority Robert L. Leahy describes ways to help clients identify and modify problematic thoughts, core beliefs, and patterns of worry, self-criticism, and approval-seeking; evaluate personal schemas; cope with painful emotions; and take action to achieve their goals. Each technique includes vivid case examples and sample dialogues. Featuring 125 reproducible forms, the print book has a large-size format for easy photocopying; purchasers also get access to a Web page where they can download and print the reproducible materials. -- |
| cost benefit analysis therapy: Special Report to the U.S. Congress on Alcohol and Health from the Secretary of Health and Human Services , 1997 |
| cost benefit analysis therapy: Journal of the National Cancer Institute , 1990 |
| cost benefit analysis therapy: Narcissism For Dummies Laura L. Smith, 2023-07-25 Recognize narcissists in your life and set healthy boundaries to start healing today Narcissism For Dummies pulls back the curtain on a growing and misunderstood personality. This book digs into dimensions of narcissism, grandiosity, malignancy, and vulnerability, giving you the knowledge and perspective you need to identify narcissists in your life and set limits on unacceptable behavior. It also takes a look at how society plays a part in fostering narcissism, for example through social media. You'll walk away from Narcissism For Dummies with a clearer sense of the personality trait, as well as necessary coping mechanisms and tools to deal with the narcissists in your life. Deal with narcissistic parents, bosses, coworkers, relatives, romantic partners, and beyond Discover tactics and exercises for identifying, disarming, and protecting yourself from narcissists Set limits, establish healthy boundaries, and rebuild your self-confidence Understand narcissistic personality in all its manifestations Anyone whose life has been touched by narcissism will find this book helpful, whether you're coming to terms with a loved one's diagnosis, dealing with a narcissist in the workplace, or working to move forward after leaving a narcissistic relationship. |
| cost benefit analysis therapy: National Cancer Institute Economic Conference, the Integration of Economic Outcome Measures Into NCI-Sponsored Therapeutic Trials , 1995 |
| cost benefit analysis therapy: Evidence-Based Cardiology Salim Yusuf, John A. Cairns, A. John Camm, Ernest L. Fallen, Bernard J. Gersh, 2008-04-15 This second editionis a ground-breaking clinical text with a strong emphasis on rigorous evidence. Leaders in the field discuss best practice in the light of systematic reviews and randomised control trials, and how best to treat where the information is less clear. Case histories provide intriguing discussions on how to apply the evidence in real life situations. Evidence-based Cardiology also includes free access to the latest evidence, which is automatically posted on a companion website. |
| cost benefit analysis therapy: The Effectiveness and costs of alcoholism treatment , |
| cost benefit analysis therapy: Comprehensive Dermatologic Drug Therapy Stephen E Wolverton, MD, 2012-11-16 Safely and effectively treat a full range of skin disorders with Comprehensive Dermatologic Drug Therapy, 3rd Edition! This trusted dermatology reference provides concise, complete, up-to-date guidance on today's full spectrum of topical, intralesional, and systemic drugs. Dr. Steven E. Wolverton and a team of leading international experts clearly explain what drugs to use, when to use them, and what to watch out for. Prescribe with confidence thanks to quick-access summaries of indications/contraindications, dosage guidelines, drug interactions, drug monitoring guidelines, adverse effects, and treatment protocols. Assess your knowledge and prepare for certification or recertification with more than 800 review questions and answers throughout the book. Contain costs and meet patient expectations with purchase information provided for major drugs. Quickly evaluate drug options for each disease discussed using a highly detailed, disease-specific index. Discover the best uses for new biologic therapeutics such as ustekinumab and rituximab, as well as newly improved TNF inhibitors. Offer your patients the very latest in cosmetic procedures, including chemical peels, intradermal fillers, and botulinum toxin. Use the safest and most effective drugs possible with new chapters on irritants and allergens in topical therapeutic agents, plus a new, separate chapter on mycophenolate mofetil. Review drugs recently taken off the market by the FDA, and use that knowledge to improve your current dermatologic drug therapy. Access the complete contents online at www.expertconsult.com and perform rapid searches for drug indications, interactions, monitoring guidelines, and much more. |
| cost benefit analysis therapy: Pharmaceutical Biotechnology Daan J. A. Crommelin, Robert D. Sindelar, Bernd Meibohm, 2013-10-22 This introductory text explains both the basic science and the applications of biotechnology-derived pharmaceuticals, with special emphasis on their clinical use. It serves as a complete one-stop source for undergraduate/graduate pharmacists, pharmaceutical science students, and for those in the pharmaceutical industry. The Fourth Edition will completely update the previous edition, and will also include additional coverage on the newer approaches such as oligonucleotides, siRNA, gene therapy and nanotech. |
| cost benefit analysis therapy: Handbook of Research on Cost-benefit Analysis Robert J. Brent, 2009 This Handbook provides an authoritative overview of current research in the field of cost-benefit analysis and is designed as a starting point for those interested in undertaking advanced research. The Handbook contains major contributions to the development of the field, focussing on standard microeconomic policy evaluations, the relatively neglected area of macroeconomic policy and its integration into a formal CBA framework, and dynamic considerations in CBA Presenting insights from many influential thinkers, and edited by a leading academic in the field, this comprehensive work will prove an invaluable reference tool for economists, researchers and scholars. |
| cost benefit analysis therapy: Evaluating the Cost-Effectiveness of Counselling in Health Care Nancy Rowland, Keith Tolley, 2021-03-04 Limited resources in health care mean that the value of counselling is decided in a highly competitive economic arena. Keith Tolley and Nancy Rowland have written a practical guide to the basic principles of evaluating cost-effectiveness to enable counsellors and service providers to carry out analysis for themselves. They provide helpful definitions of technical terms and use case studies to demonstrate how to apply the theory in different contexts. |
| cost benefit analysis therapy: Matching Treatment to Patient Needs in Opioid Substitution Therapy Janice Fay Kauffman, 1995 |
| cost benefit analysis therapy: Neuraxial Therapeutics Tony Yaksh, Salim Hayek, 2024-01-02 This book is a comprehensive reference of the neuraxial route for the delivery of therapeutics. It reviews the historical evolution of this approach from its inception in the later 1800's to present day. This amply referenced text covers basic discussions of spinal anatomy, embryogenesis, neuraxial vascularity, cerebrospinal fluid flow dynamics and parenchymal molecule movement. The pharmacokinetic and pharmacodynamic properties of different intrathecal agents are explored in detail with particular reference to clinical correlates in pain and spasticity. Particular attention is paid to the issues relevant to preclinical models of intrathecal delivery and the assessment of spinal pathologies arising from acute and chronic intrathecal drug delivery. Chapters provide essential discussions of clinical aspects of patient care, including patient evaluation and screening, trialing and device management, troubleshooting problems and addressing complications, best practices, cost-effectiveness and future of the therapy. Clinicians and researchers who practice intrathecal therapy and study neuraxial mechanisms will find Neuraxial Therapeutics, to be an invaluable guide to this treatment modality. |
| cost benefit analysis therapy: Child Abuse and Neglect and Family Violence Thesaurus , 1988 |
| cost benefit analysis therapy: Cognitive Therapy Techniques Robert L. Leahy, 2003-07-29 An indispensable clinical companion, this book is packed with useful tools and interventions that will expand the repertoire of novice and experienced cognitive therapists. Detailed are the full variety of evidence-based techniques that can be brought to bear on specific client problems and therapeutic challenges. Therapists will rediscover--or learn for the first time--a wealth of effective ways to identify and challenge thoughts and core beliefs; modify patterns of worry, self-criticism, and approval-seeking; evaluate personal schemas; intervene in emotional processes; and activate new experiences for the client. Each technique is thoroughly described in Robert L. Leahy's trademark accessible style and illustrated with vivid case examples. Designed in a convenient large-size format, the book is bursting with over 80 reproducible client forms and handouts. Photocopy Rights The Publisher grants individual book purchasers nonassignable permission to reproduce selected materials in this book for professional use. For details and limitations, see copyright page. Key Features: For clinicians who know the basics, here is the entire range of therapeutic techniques clearly articulated in a user-friendly format. Author is well known and highly respected. Includes forms, handouts, homework assignments, and numerous concrete examples. |
| cost benefit analysis therapy: Neuromodulation Elliot Krames, P. Hunter Peckham, Ali R. Rezai, 2018-01-05 Neuromodulation: Comprehensive Textbook of Principles, Technologies, and Therapies, Second Edition, serves as a comprehensive and in-depth reference textbook covering all aspects of the rapidly growing field of neuromodulation. Since the publication of the first edition seven years ago, there has been an explosion of knowledge in neuromodulation, optogenetics, bioelectronics medicine and brain computer interfacing. Users will find unique discussions of the fundamental principles of neuromodulation and therapies, and how they are applied to the brain, spinal cord, peripheral nerves, autonomic nerves and various organs. The book focuses on comprehensive coverage of spinal cord stimulation, non-interventional and interventional brain stimulation, peripheral nerve stimulation, and the emerging fields of neuromodulation, including optogenetics and bioelectronics medicine. - Provides a comprehensive reference that covers all aspects of the growing field of neuromodulation - Written by international, leading authorities in their respective fields of neuromodulation, pain management, functional neurosurgery and biomedical engineering - Includes new chapters on optogenetics, bioelectronics medicine and brain computer interfacing |
| cost benefit analysis therapy: Thesaurus of ERIC Descriptors , 1990 4th-7th eds. contain a special chapter on The role and function of the thesaurus in education, by Frederick Goodman. |
Costco Wholesale Corporation (COST) - Yahoo Finance
Find the latest Costco Wholesale Corporation (COST) stock quote, history, news and other vital information to help you with your stock trading and investing.
COST Stock Price | Costco Wholesale Corp. Stock Quote (U.S ...
3 days ago · COST | Complete Costco Wholesale Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
COST Definition & Meaning - Merriam-Webster
The meaning of COST is the amount or equivalent paid or charged for something : price. How to use cost in a sentence.
COST | English meaning - Cambridge Dictionary
COST definition: 1. the amount of money needed to buy, do, or make something: 2. the amount of money needed for a…. Learn more.
Cost - definition of cost by The Free Dictionary
cost - value measured by what must be given or done or undergone to obtain something; "the cost in human life was enormous"; "the price of success is hard work"; "what price glory?"
Cost - Definition, Meaning & Synonyms - Vocabulary.com
The cost of something is how much money you need to spend on it. The high cost of a fancy coffee drink might surprise you. A new car costs thousands of dollars, while in some places …
What is a Cost? - Definition | Meaning | Example
Definition: A cost is an expenditure required to produce or sell a product or get an asset ready for normal use. In other words, it’s the amount paid to manufacture a product, purchase inventory, …
Costco Wholesale Corporation (COST) - Yahoo Finance
Find the latest Costco Wholesale Corporation (COST) stock quote, history, news and other vital information to help you with your stock trading and investing.
COST Stock Price | Costco Wholesale Corp. Stock Quote (U.S ...
3 days ago · COST | Complete Costco Wholesale Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
COST Definition & Meaning - Merriam-Webster
The meaning of COST is the amount or equivalent paid or charged for something : price. How to use cost in a sentence.
COST | English meaning - Cambridge Dictionary
COST definition: 1. the amount of money needed to buy, do, or make something: 2. the amount of money needed for a…. Learn more.
Cost - definition of cost by The Free Dictionary
cost - value measured by what must be given or done or undergone to obtain something; "the cost in human life was enormous"; "the price of success is hard work"; "what price glory?"
Cost - Definition, Meaning & Synonyms - Vocabulary.com
The cost of something is how much money you need to spend on it. The high cost of a fancy coffee drink might surprise you. A new car costs thousands of dollars, while in some places …
What is a Cost? - Definition | Meaning | Example
Definition: A cost is an expenditure required to produce or sell a product or get an asset ready for normal use. In other words, it’s the amount paid to manufacture a product, purchase inventory, …
